These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3095083)

  • 1. [Lung parenchyma disease following instillation of mitomycin C in the bladder].
    Wilhelms E; Criée CP; Neubauer H; Neuhaus KL
    Dtsch Med Wochenschr; 1986 Oct; 111(41):1564-6. PubMed ID: 3095083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary fibrosis following instillation of mitomycin C in the urinary bladder].
    Neubauer H; Blech M; Wilhelms E; Crieé CP; Neuhaus KL; Truss F
    Urologe A; 1987 Jan; 26(1):41-3. PubMed ID: 3107190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer.
    Baker WC; Russo MA; deVere White RW
    Urology; 1987 Oct; 30(4):357-8. PubMed ID: 3116739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer.
    Drago PC; Badalament RA; Lucas J; Drago JR
    J Urol; 1989 Oct; 142(4):1071-2. PubMed ID: 2507794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severely contracted bladder following intravesical mitomycin C therapy.
    Wajsman Z; McGill W; Englander L; Huben RP; Pontes JE
    J Urol; 1983 Aug; 130(2):340-1. PubMed ID: 6410085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal failure after intravesical mitomycin C.
    Farha AJ; Krauss DJ
    Urology; 1989 Oct; 34(4):216-7. PubMed ID: 2508290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Complications of intravesical mitomycin chemotherapy, apropos of 2 clinical case reports].
    Pouya M; Opsomer RJ; Wese FX; Saleh M; Donnay M; Van Cangh PJ
    Acta Urol Belg; 1996 Mar; 64(1):47-53. PubMed ID: 8659335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH; Bouffioux C; Sylvester R; de Pauw M
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.
    van der Meijden AP; DeBruyne FM
    Urology; 1988 Mar; 31(3 Suppl):26-9. PubMed ID: 3126592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels during intravesical instillation of mitomycin-C.
    Kurth KH; de Wall JG; van Oosterom AT; de Jong EA; Tjaden UR
    Prog Clin Biol Res; 1985; 185B():81-93. PubMed ID: 3929272
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergy to mitomycin C complicating topical administration for urothelial cancer.
    Inglis JA; Tolley DA; Grigor KM
    Br J Urol; 1987 Jun; 59(6):547-9. PubMed ID: 3120846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.
    DeFuria MD; Bracken RB; Johnson DE; Soloway MS; Merrin CE; Morgan LR; Miller HC; Crooke ST
    Cancer Treat Rep; 1980; 64(2-3):225-30. PubMed ID: 7407754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatitis due to mitomycin C bladder instillations: study of 2 cases.
    Arregui MA; Aguirre A; Gil N; Goday J; Ratón JA
    Contact Dermatitis; 1991 May; 24(5):368-70. PubMed ID: 1832619
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of mitomycin C perfusion after bladder tumor surgery].
    Zhou CL
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):654-5, 700. PubMed ID: 2517250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitomycin C resorption following repeated intravesical instillations using different instillation times.
    van Helsdingen PJ; Rikken CH; Sleeboom HP; de Bruyn EA; Tjaden UR
    Urol Int; 1988; 43(1):42-6. PubMed ID: 3131943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patients.
    Prout GR; Griffin PP; Nocks BN; DeFuria MD; Daly JJ
    J Urol; 1982 Jun; 127(6):1096-8. PubMed ID: 6806488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood and tissue levels of mitomycin C after intravesical instillation].
    Flüchter SH; Hlobil H; Harzmann R; Rothe KF; Bichler KH
    Urol Int; 1983; 38(6):321-8. PubMed ID: 6419427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical mitomycin C for superficial transitional cell carcinoma.
    Bolenz C; Cao Y; Arancibia MF; Trojan L; Alken P; Michel MS
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1273-82. PubMed ID: 16925493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Toxicoallergic exanthema caused by intravesical instillation of mitomycin C].
    Sala F; Crosti C; Bencini PL; Perotta E; Mansi M
    G Ital Dermatol Venereol; 1987 May; 122(5):265-7. PubMed ID: 2957314
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of intravesical mitomycin C in the treatment of superficial transitional cell carcinoma of the urinary bladder.
    Pavlotsky A; Eidelman A; Barak F; Alon H; Horn Y
    J Surg Oncol; 1989 May; 41(1):9-11. PubMed ID: 2497274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.